[Treatment for recurrent uterine cancer].
Sagae
Satoshi
S
Dept. of Gynecology and Obstetrics, JR Sapporo Railway Hospital, Hokkaido, Japan
Sugimura
Masaki
M
Nagata
Masami
M
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D012008:Recurrence; D014594:Uterine Neoplasms / Q000378:metabolism / Q000601:surgery / Q000628:therapy*
D000970:Antineoplastic Agents